Wilms tumors in patients with constitutional WT1 mutations are examples of Knudson's tumor suppressor paradigm, with somatic inactivation of the second allele occurring through 11p loss of heterozygosity. The time point of this second hit has remained unknown. We analyzed seven Wilms tumors from two patients with constitutional WT1 mutations by whole exome sequencing and genomic array. All tumors exhibited wild type WT1 loss through uniparental isodisomy.
INTRODUCTION
In 1972, Knudson and Strong suggested a two-mutational model for familial and multifocal cases of Wilms tumors, where one mutation is inherited and the other lost in the somatic line. 1 This hypothesis was confirmed by identification of the WT1 gene in 11p13, exhibiting germline mutations and deletions in the Denys-Drash and Wilms tumor, aniridia, genitourinary anomalies, mental retardation (WAGR) syndromes and somatic loss/inactivation of the normal WT1 allele in the associated tumors. [2] [3] [4] [5] For patients with WAGR, it has been shown that different tumors in the same individual typically have different mutational status regarding the second WT1 allele, indicating independent origin. 6, 7 However, little is still known regarding the timing of wild type allele loss in patients with inherited WT1 point mutation.
In theory, the loss could occur during nephrogenesis, leading to clonal patches that each provides substrate for several tumors (Supplementary Figure S1 ). Some tumors would then share the same mechanism for allelic loss. Alternatively, wild type WT1 loss could be concomitant to transformation of each tumor's founder cell. Each tumor would Abbreviations: NSS, nephron-sparing surgery; WAGR, Wilms tumor, aniridia, genitourinary anomalies, mental retardation syndrome; WES, whole exome sequencing then have its own unique mode of second allele WT1 loss. Finally, other mutations could act as a trigger for tumorigenesis, and second allele WT1 mutation could be a later step. Wild type allele losses could then be detected as subclonal events. To assess these scenarios, we analyzed multiple Wilms tumors from two individuals with constitutional WT1 mutations. The balanced heterozygous state corresponds to data points at allelic difference = 0 (vertical center), homozygous states to +1.0 and -1.0, hemizygous deletions (-) to +0.5 and -0.5, trisomic gains (+) to +1.5 and -1.5, and copy number neutral imbalances (cnni, uniparental isodisomies) to stretches of homozygosity in the absence of heterozygous states. Below each allele plot is a cytogenetic regional map. Different breakpoints leading to cnni(11p) ( , etc.) are specified to illustrate parallel/convergent evolution, which is also denoted by boxes of the same color around the symbol for each aberration. Detailed data on array profiles are provided in Supplementary Table S2 F I G U R E 2 Features of convergent evolution detected by whole exome sequencing; mutation status of tumors in Patients 1 and 2 subjected to whole exome sequencing. Features of parallel/convergent evolution are in blue type for 11p alterations and green type for 3p alterations, including CTNNB1 mutations and allelic 3p imbalances detected by single nucleotide polymorphism array. Detailed data on mutations are provided in Supplementary Table S2 (Supplementary Table S1 , Supplementary Figure S2 ). 8 The patient was found to exhibit a de novo constitutional WT1 frameshift mutation c.289del (p.Ser97Profs). Fresh tumor and matched kidney samples were subjected to DNA extraction followed by whole genome genotyping using the CytoScan HD array (Thermo Fisher Scientific/Affymetrix Inc., Santa Clara, CA). 9 Ploidy and copy number were deduced by the combination of log2 ratio and allelic difference using the Tumor Aberration Prediction Suite. 10 Whole exome sequencing (WES) was performed, 11 with a median depth of 120× for tumors and 60× for normal tissue. The percentage of cells containing a certain genetic alteration was calculated from log2 ratios, allelic differences, and variant allele frequencies in combination with copy number. 11 
METHODS AND PATIENTS

RESULTS
For patient 1, one sample from the first tumor (T1) and two samples from the second tumor (T2A and T2B) were analyzed (Supplementary Table S2 ). For patient 2, material was available for genetic analysis from five tumors (T1-T5). Each of the seven tumors had a copy number neutral imbalance (cnni, partial uniparental isodisomy) of the short arm of chromosome 11 (Figure 1) . In all tumors, the cnni(11p) stretched from terminal 11p to include the WT1 locus. However, the proximal break- 
DISCUSSION
The finding of a unique 11p breakpoint in each of the analyzed tumors argues against the notion that multifocal tumors emerge from a field of biallelic WT1 inactivation. The same scenario of private mutations was found for CTNNB1, the exception being the p. alterations. 12, 13 Thus, the most plausible scenario is that each tumor in our patients stems from a founder cell lineage in which 11p allele loss occurs close to the point where monoclonal expansion starts, followed by CTNNB1 mutation. Further accumulation of large-scale genomic anomalies appears to be rare after this point, in contrast to the situation in sporadic Wilms tumors. 9, 11, 14 
